IP Library Granted Patent US 11,154,495
Granted Patent B2
US 11,154,495 · App. 15/092,332 · Granted Oct 26, 2021

Multicomponent gummy compositions with soft core

Inventors: Ovidiu Romanoschi (Highland Park, NJ); Caryn Oryniak (Hillsborough, NJ); Luis Muniz (Brooklyn, NY); Lindsey Bagley (Berkshire, GB); Graham Godfrey (Worcestershire, GB); Hiep Huatan (Maidstone, GB)
Assignee: Church & Dwight Co., Inc.
A61K9/0056A23G3/36A23G3/54A61K9/2009A61K9/2013A61K9/2018A61K9/2027A61K9/2054A61K9/2072A61K31/167A61K31/19A61K31/197A61K31/375A61K31/4545A61K31/519A61K31/616A61K33/42A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,154,495
App. No.
15/092,332
Granted
Oct 26, 2021
Kind
B2
Abstract

The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of a first component including a gummy composition, at least one further component including a composition that is different from the gummy composition, and an active ingredient. The gummy composition and the second composition can be co-deposited to form multicomponent dosage forms wherein a gummy shell at least partially surrounds a core that is solid or liquid at standard temperature.

Claims (35)

1. A chewable, multicomponent composition for oral administration, the multicomponent composition comprising:

a first component that is a hydrocolloid system comprising 70% to about 94% w/w of one or more hydrophilic bulking agents, about 1% to about 20% w/w of one or more hydrophilic, long-chain polymers, and about 5% to about 35% w/w of a water source, the first component being in the form of a gel;

a second component comprising a lipidic base in an amount of about 20% to about 70% by weight of the second component and one or more hydrophilic bulking agents in an amount of about 10% to about 70% by weight of the second component, the lipidic base having a melting temperature of about 10° C. to about 50° C., wherein the second component is solid at a temperature of about 35° C. or less and is a viscous fluid at a temperature of about 40° C. to about 100° C.; and

an active ingredient;

wherein the second component is at least partially surrounded by the first component.

2. The multicomponent composition of claim 1 , wherein the composition is in a core/shell conformation with the first component forming a shell surrounding at least one core formed of the second component.

3. The multicomponent composition of claim 2 , wherein the first component has a thickness, measured as the distance between an outer surface of the at least one core, and an outer surface of the first component, of about 1 mm or greater at all points.

4. The multicomponent composition of claim 1 , wherein one or more of the following conditions is met:

the active ingredient is included in the second component;

the active ingredient is included in the first component;

a plurality of active ingredients are included;

the active ingredient is in an encapsulated form;

the hydrocolloid system of the first component is elastic or viscoelastic;

the hydrocolloid system has a solids content of at least about 78% by weight.

5. The multicomponent composition of claim 1 , wherein the active ingredient is a natural or synthetic substance that is recognized as being beneficial to human health and is selected from the group consisting of non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, antihistamines, decongestants, antitussives, expectorants, sleep aids, antibiotics, laxatives, anti-diarrheals, anthelmintics, antacids, vitamins, minerals, phytonutrients, fiber, fatty acids, amino acids, polypeptides, botanicals, herbs, prebiotics, probiotics, and combinations thereof.

6. The multicomponent composition of claim 1 , wherein one or more of the following conditions is met:

the one or more hydrophilic bulking agents of the first component includes one or more saccharides or saccharide derivatives;

the one or more hydrophilic bulking agents of the first component includes one or more hydrogenated carbohydrates;

the one or more hydrophilic bulking agents of the first component includes one or both of sugar solids and granulated sugar;

the one or more hydrophilic bulking agents of the first component includes glucose, sucrose, and sorbitol.

7. The multicomponent composition of claim 1 , wherein the second component, in the form of a viscous fluid, has a viscosity of about 0.01 to about 30 PaS at a temperature of about 50° C.

8. The multicomponent composition of claim 1 , wherein the hydrophilic bulking agent and the lipidic base in the second component are present in a ratio of about 0.2 to about 0.8.

9. The multicomponent composition of claim 1 , wherein the hydrophilic bulking agent in the second component comprises a material selected from the group consisting of saccharides, saccharide derivatives, hydrogenated carbohydrates, emulsifiers, proteins, processing aids, inorganic salts, active ingredients, and combinations thereof.

10. The multicomponent composition of claim 9 , wherein one or both of the following conditions is met:

the hydrophilic bulking agent in the second component is selected from the group consisting of sucrose, glucose, dextrose, maltose, variations thereof, and combinations thereof;

the hydrophilic bulking agent in the second component is selected from the group consisting of sorbitol, glycerol, mannitol, maltitol, erythritol, lactitol, isomalt, and combinations thereof.

11. The multicomponent composition of claim 1 , wherein the first component is a hydrocolloid system comprising about 70% to about 94% w/w of one or more saccharides or saccharide derivatives, about 1% to about 15% w/w of one or more hydrophilic, long-chain polymers comprising at least pectin, and about 10% to about 25% w/w of a water source, the first component being in the form of a gel.

12. The multicomponent composition of claim 1 , wherein the first component is one or both of: configured to be reduced to smaller pieces through mastication; and configured to dissolve within the mouth.

13. The multicomponent composition of claim 1 , wherein the first component has a water activity awl, the second component has a water activity a w 2, and a w 1 is greater than a w 2 prior to combining the first component and the second component.

14. The multicomponent composition of claim 13 , wherein a w 1 is greater than a w 2 by at least 0.05.

15. The multicomponent composition of claim 14 , wherein one of the following conditions is met:

a w 1 is about 0.65 or greater;

a w 1 is about 0.5 to about 0.65.

16. The multicomponent composition of claim 1 , wherein the lipidic base is a fat from one or more of a vegetable source, an animal source, a nut source, and a seed source.

17. The multicomponent composition of claim 1 , wherein the lipidic base is a fat from one or more of cocoa, palm, and coconut.

Assignments (9)
ASSIGNMENT Recorded Jan 22, 2026
From: CHURCH & DWIGHT CO., INC.
To: AHAFCD LLC
Reel/Frame 074247/0428 →
SECURITY INTEREST Recorded Dec 31, 2025
From: AHAFCD LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073345/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: EUREKA
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 038552/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: GODFREY, GRAHAM
To: GRAHAM GODFREY CONSULTANCY LTD
Reel/Frame 038552/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: ROMANOSCHI, OVIDIU; ORYNIAK, CARYN; MUNIZ, LUIS C.
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 038552/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: HUATAN, HIEP
To: H2 PHARMA CONSULTING LIMITED
Reel/Frame 038552/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: H2 PHARMA CONSULTING LIMITED
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 038553/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: GRAHAM GODFREY CONSULTANCY LTD
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 038552/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: BAGLEY, LINDSEY
To: EUREKA
Reel/Frame 038552/0473 →
Continuity (3)
Provisional Application 62144224 · Apr 7, 2015
Provisional Application 62238947 · Oct 8, 2015
Related Publication 20160296470A1 · Oct 13, 2016